The changing epidemiology of Staphylococcus aureus bloodstream infection: A multinational population-based surveillance study

Clinical Microbiology and Infection

Volumn 19, Issue 5, 2013, Pages 465-471

  Laupland, K B ^a   Lyytikainen O ^b   Sogaard M ^c   Kennedy, K J ^d   Knudsen, J D ^e   Ostergaard, C ^f   Galbraith, J C ^g   Valiquette, L ^h   Jacobsson, G ⁱ   Collignon, P ^d   Schonheyder H C ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^e HVIDOVRE HOSPITAL   (Denmark)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g ROYAL JUBILEE HOSPITAL   (Canada)

^h UNIVERSITÉ DE SHERBROOKE   (Canada)

ⁱ SKARABORG HOSPITAL   (Sweden)

Author keywords

Bacteraemia; Incidence; Population; Secular trends

Indexed keywords

ARTICLE; AUSTRALIA; BLOODSTREAM INFECTION; CANADA; DENMARK; DISEASE SURVEILLANCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SWEDEN;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84876325075     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03903.x     Document Type: Article

References (34)

1. Uslan DZ, Crane SJ, Steckelberg JM et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted county, Minnesota. Arch Intern Med 2007; 167: 834-839.
2. Madsen KM, Schonheyder HC, Kristensen B, Sorensen HT. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981-1994. APMIS 1999; 107: 346-352.
3. Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. Severe bloodstream infections: a population-based assessment. Crit Care Med 2004; 32: 992-997.
4. Lyytikainen O, Ruotsalainen E, Jarvinen A, Valtonen V, Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis 2005; 24: 399-404.
5. Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003; 187: 1452-1459.
6. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198: 336-343.
7. Tong SY, Bishop EJ, Lilliebridge RA et al. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis 2009; 10: 1461-1470.
8. Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 2007; 39: 6-13.
9. Frederiksen MS, Espersen F, Frimodt-Moller N et al. Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000. Pediatr Infect Dis J 2007; 26: 398-405.
10. Benfield T, Espersen F, Frimodt-Moller N et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13: 257-263.
11. Collignon P, Nimmo GR, Gottlieb T, Gosbell IB. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005; 11: 554-561.
12. Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Epidemiology of Staphylococcus aureus bacteraemia in Denmark from 1957 to 1990. Clin Microbiol Infect 1997; 3: 297-305.
13. Allard C, Carignan A, Bergevin M et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect 2008; 14: 421-428.
14. Asgeirsson H, Kristjansson M, Kristinsson KG, Gudlaugsson O. Staphylococcus aureus bacteraemia-nationwide assessment of treatment adequacy and outcome. J Infect 2011; 62: 339-346.
15. El Atrouni WI, Knoll BM, Lahr BD, Eckel-Passow JE, Sia IG, Baddour LM. Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted county, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis 2009; 49: e130-e138.
16. Huggan PJ, Wells JE, Browne M, Richardson A, Murdoch DR, Chambers ST. Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Intern Med J 2010; 40: 117-125.
17. Miller LG, Perdreau-Remington F, Rieg G et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352: 1445-1453.
18. Khairulddin N, Bishop L, Lamagni TL, Sharland M, Duckworth G. Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990-2001. Arch Dis Child 2004; 89: 378-379.
19. Gilbert M, MacDonald J, Gregson D et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006; 175: 149-154.
20. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771.
21. Li F, Park SY, Ayers TL et al. Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002. Emerg Infect Dis 2005; 11: 1205-1210.
22. Paul J. Surveillance and management of all types of Staphylococcus aureus bacteraemia. BMJ 2006; 333: 269-270.
23. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281-284.
24. Griffiths C, Lamagni TL, Crowcroft NS, Duckworth G, Rooney C. Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993-2002. Health Stat Q 2004; 21: 15-22.
25. Mostofsky E, Lipsitch M, Regev-Yochay G. Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?J Antimicrob Chemother 2011; 66: 2199-2214.
26. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009; 64 (suppl 1): i11-i17.
27. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?Clin Infect Dis 2008; 46: 787-794.
28. Manian FA, Griesnauer S. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) is replacing traditional health care-associated MRSA strains in surgical-site infections among inpatients. Clin Infect Dis 2008; 47: 434-435.
29. Lessa FC, Mu Y, Davies J et al. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis 2010; 8: 925-928.
30. Laupland KB, Schonheyder HC, Kennedy KJ et al. Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative. BMC Res Notes 2009; 2: 146.
31. Kennedy KJ, Roberts JL, Collignon PJ. Escherichia coli bacteraemia in Canberra: incidence and clinical features. Med J Aust 2008; 4: 209-213.
32. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008; 14: 1041-1047.
33. Skogberg K, Lyytikainen O, Ruutu P, Ollgren J, Nuorti JP. Increase in bloodstream infections in Finland, 1995-2002. Epidemiol Infect 2008; 136: 108-114.
34. Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-797.